Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ondrej Cehlar

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
General Physiology and Biophysics|December 13, 2021
The structure of the unstructured: mosaic of tau protein linear motifs obtained by high-resolution techniques and molecular simulationOndrej Cehlar, Olga Bagarova, Lenka Hornakova, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2018
Tau Conformation as a Target for Disease-Modifying Therapy: The Role of TruncationPetr Novak, Ondrej Cehlar, Rostislav Skrabana, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|October 3, 2012
Crystallization and preliminary X-ray diffraction analysis of tau protein microtubule-binding motifs in complex with Tau5 and DC25 antibody Fab fragmentsOndrej Cehlar, Rostislav Skrabana, Andrej Kovac, et al.
International Journal of Molecular Sciences|December 17, 2024
Structures of Oligomeric States of Tau Protein, Amyloid-β, α-Synuclein and Prion Protein Implicated in Alzheimer's Disease, Parkinson's Disease and PrionopathiesOndrej Cehlar, Stefana Njemoga, Marian Horvath, et al.
Assay and Drug Development Technologies|February 16, 2022
A New Spectral Shift-Based Method to Characterize Molecular InteractionsAndreas Langer, Tanja Bartoschik, Ondrej Cehlar, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|October 3, 2012
Crystallization and preliminary X-ray diffraction analysis of two peptides from Alzheimer PHF in complex with the MN423 antibody Fab fragmentRostislav Skrabana, Ondrej Cehlar, Zuzana Flachbartova, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Lactoferrin Binds through Its N-Terminus to the Receptor-Binding Domain of the SARS-CoV-2 Spike ProteinPatrik Babulic, Ondrej Cehlar, Gabriela Ondrovičová, et al.
International Journal of Biological Macromolecules|April 19, 2026
Gradual N-terminal truncation of tau dGAE (297-391) reveals the importance of 321-325 sequence for early steps of fibril formationStefana Njemoga, Petra Majerova, Juraj Piestansky, et al.
Pharmaceutics|April 28, 2023
Time to Kill and Time to Heal: The Multifaceted Role of Lactoferrin and Lactoferricin in Host DefenseAnna Ohradanova-Repic, Romana Praženicová, Laura Gebetsberger, et al.
FEBS Letters|March 24, 2022
Interaction kinetics reveal distinct properties of conformational ensembles of three-repeat and four-repeat tau proteinsLenka Hornakova, Jakub Sinsky, Maria Janubova, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
General Physiology and Biophysics|December 13, 2021
The structure of the unstructured: mosaic of tau protein linear motifs obtained by high-resolution techniques and molecular simulationOndrej Cehlar, Olga Bagarova, Lenka Hornakova, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2018
Tau Conformation as a Target for Disease-Modifying Therapy: The Role of TruncationPetr Novak, Ondrej Cehlar, Rostislav Skrabana, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|October 3, 2012
Crystallization and preliminary X-ray diffraction analysis of tau protein microtubule-binding motifs in complex with Tau5 and DC25 antibody Fab fragmentsOndrej Cehlar, Rostislav Skrabana, Andrej Kovac, et al.
International Journal of Molecular Sciences|December 17, 2024
Structures of Oligomeric States of Tau Protein, Amyloid-β, α-Synuclein and Prion Protein Implicated in Alzheimer's Disease, Parkinson's Disease and PrionopathiesOndrej Cehlar, Stefana Njemoga, Marian Horvath, et al.
Assay and Drug Development Technologies|February 16, 2022
A New Spectral Shift-Based Method to Characterize Molecular InteractionsAndreas Langer, Tanja Bartoschik, Ondrej Cehlar, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|October 3, 2012
Crystallization and preliminary X-ray diffraction analysis of two peptides from Alzheimer PHF in complex with the MN423 antibody Fab fragmentRostislav Skrabana, Ondrej Cehlar, Zuzana Flachbartova, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Lactoferrin Binds through Its N-Terminus to the Receptor-Binding Domain of the SARS-CoV-2 Spike ProteinPatrik Babulic, Ondrej Cehlar, Gabriela Ondrovičová, et al.
International Journal of Biological Macromolecules|April 19, 2026
Gradual N-terminal truncation of tau dGAE (297-391) reveals the importance of 321-325 sequence for early steps of fibril formationStefana Njemoga, Petra Majerova, Juraj Piestansky, et al.
Pharmaceutics|April 28, 2023
Time to Kill and Time to Heal: The Multifaceted Role of Lactoferrin and Lactoferricin in Host DefenseAnna Ohradanova-Repic, Romana Praženicová, Laura Gebetsberger, et al.
FEBS Letters|March 24, 2022
Interaction kinetics reveal distinct properties of conformational ensembles of three-repeat and four-repeat tau proteinsLenka Hornakova, Jakub Sinsky, Maria Janubova, et al.
Pageof 2